A fusion-loop antibody enhances the infectious properties of immature flavivirus particles

Journal of Virology

Volumn 85, Issue 22, 2011, Pages 11800-11808

  Rodenhuis Zybert, Izabela A ^a   Moesker, Bastiaan ^a   da Silva Voorham, Júlia M ^a   van der Ende Metselaar, Heidi ^a   Diamond, Michael S ^b   Wilschut, Jan ^a   Smit, Jolanda M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FURIN; HYBRID PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY E53; PEPTIDE; PRM ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN;

ACIDITY; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DENGUE VIRUS; ENDOSOME; ENZYME ACTIVITY; FLAVIVIRUS INFECTION; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; VIRION; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS PARTICLE; WEST NILE FLAVIVIRUS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIBODY-DEPENDENT ENHANCEMENT; CELL LINE; CRICETINAE; DENGUE VIRUS; FURIN; HYDROGEN-ION CONCENTRATION; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION; WEST NILE VIRUS;

DENGUE VIRUS; FLAVIVIRUS; WEST NILE VIRUS;

EID: 80655125500     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05237-11     Document Type: Article

References (35)

1. Balsitis, S. J., et al. 2010. Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog. 6:e1000790.
2. Cain, C. C., and R. F. Murphy. 1988. A chloroquine-resistant Swiss 3T3 cell line with a defect in late endocytic acidification. J. Cell Biol. 106:269-277.
3. Cherrier, M. V., et al. 2009. Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody. EMBO J. 28:3269-3276.
4. Crill, W. D., and J. T. Roehrig. 2001. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J. Virol. 75:7769-7773.
5. Dejnirattisai, W., et al. 2010. Cross-reacting antibodies enhance dengue virus infection in humans. Science 328:745-748.
6. Diamond, M. S., D. Edgil, T. G. Roberts, B. Lu, and E. Harris. 2000. Infection of human cells by dengue virus is modulated by different cell types and viral strains. J. Virol. 74:7814-7823.
7. Elshuber, S., S. L. Allison, F. X. Heinz, and C. W. Mandl. 2003. Cleavage of protein prM is necessary for infection of BHK-21 cells by tick-borne encephalitis virus. J. Gen. Virol. 84:183-191.
8. Halstead, S. B., and E. J. O'Rourke. 1977. Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265:739-741.
9. Heinz, F. X., et al. 1994. Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM. Virology 198:109-117.
10. Junjhon, J., et al. 2010. Influence of pr-M cleavage on the heterogeneity of extracellular dengue virus particles. J. Virol. 84:8353-8358.
11. Kanai, R., et al. 2006. Crystal structure of West Nile virus envelope glycoprotein reveals viral surface epitopes. J. Virol. 80:11000-11008.
12. Kuhn, R. J., et al. 2002. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108:717-725.
13. Li, L., et al. 2008. The flavivirus precursor membrane-envelope protein complex: structure and maturation. Science 319:1830-1834.
14. Lindenbach, B. D., and C. M. Rice. 2003. Molecular biology of flaviviruses. Adv. Virus Res. 59:23-61.
15. Mackenzie, J. M., and E. G. Westaway. 2001. Assembly and maturation of the flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively. J. Virol. 75:10787- 10799.
16. Mehlhop, E., et al. 2009. Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization of West Nile virus. Cell Host Microbe 6:381-391.
17. Moesker, B., I. A. Rodenhuis-Zybert, T. Meijerhof, J. Wilschut, and J. M. Smit. 2010. Characterization of the functional requirements of West Nile virus membrane fusion. J. Gen. Virol. 91:389-393.
18. Nelson, S., et al. 2008. Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization. PLoS Pathog. 4:e1000060.
19. Nybakken, G. E., C. A. Nelson, B. R. Chen, M. S. Diamond, and D. H. Fremont. 2006. Crystal structure of the West Nile virus envelope glycoprotein. J. Virol. 80:11467-11474.
20. Nybakken, G. E., et al. 2005. Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature 437:764-769.
21. Oliphant, T., et al. 2006. Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein. J. Virol. 80:12149-12159.
22. Pierson, T. C., et al. 2007. The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection. Cell Host Microbe 1:135-145.
23. Rodenhuis-Zybert, I. A., et al. 2010. Immature dengue virus: a veiled pathogen? PLoS Pathog. 6:e1000718.
24. Rybak, S. L., and R. F. Murphy. 1998. Primary cell cultures from murine kidney and heart differ in endosomal pH 4. J. Cell Physiol. 176:216-222.
25. +-ATPase regulation of endosomal acidification in K562 erythroleukemia cells: analysis via inhibition of transferrin recycling by low temperatures 2. J. Biol. Chem. 266:3469-3474.
26. Stadler, K., S. L. Allison, J. Schalich, and F. X. Heinz. 1997. Proteolytic activation of tick-borne encephalitis virus by furin. J. Virol. 71:8475-8481.
27. van der Schaar, H. M., et al. 2008. Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog. 4:e1000244.
28. Van, R. J., K. R. Bridges, J. B. Harford, and R. D. Klausner. 1982. Receptormediated endocytosis of transferrin and the uptake of Fe in K562 cells: identification of a nonlysosomal acidic compartment. Proc. Natl. Acad. Sci. U. S. A. 79:6186-6190.
29. Wengler, G., and G. Wengler. 1989. Cell-associated West Nile flavivirus is covered with E+pre-M protein heterodimers which are destroyed and reorganized by proteolytic cleavage during virus release. J. Virol. 63:2521-2526.
30. Yu, I. M., et al. 2008. Structure of the immature dengue virus at low pH primes proteolytic maturation. Science 319:1834-1837.
31. Zhang, Y., et al. 2003. Structures of immature flavivirus particles. EMBO J. 22:2604-2613.
32. Zhang, Y., B. Kaufmann, P. R. Chipman, R. J. Kuhn, and M. G. Rossmann. 2007. Structure of immature West Nile virus. J. Virol. 81:6141-6145.
33. Zhang, Y., et al. 2004. Conformational changes of the flavivirus E glycoprotein. Structure 12:1607-1618.
34. Zheng, A., M. Umashankar, and M. Kielian. 2010. In vitro and in vivo studies identify important features of dengue virus pr-E protein interactions. PLoS Pathog. 6:e1001157.
35. Zybert, I. A., H. van der Ende-Metselaar, J. Wilschut, and J. M. Smit. 2008. Functional importance of dengue virus maturation: infectious properties of immature virions. J. Gen. Virol. 89:3047-3051.